PT843676E - Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada - Google Patents
Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongadaInfo
- Publication number
- PT843676E PT843676E PT96927638T PT96927638T PT843676E PT 843676 E PT843676 E PT 843676E PT 96927638 T PT96927638 T PT 96927638T PT 96927638 T PT96927638 T PT 96927638T PT 843676 E PT843676 E PT 843676E
- Authority
- PT
- Portugal
- Prior art keywords
- ipratropio
- ipometer
- bromide
- length
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19528145A DE19528145A1 (de) | 1995-08-01 | 1995-08-01 | Neue Arzneimittel und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
PT843676E true PT843676E (pt) | 2002-04-29 |
Family
ID=7768353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96927638T PT843676E (pt) | 1995-08-01 | 1996-07-31 | Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada |
Country Status (37)
Country | Link |
---|---|
US (1) | US6299861B1 (pt) |
EP (1) | EP0843676B1 (pt) |
JP (1) | JPH11510150A (pt) |
KR (1) | KR100445016B1 (pt) |
CN (1) | CN1120841C (pt) |
AR (1) | AR004179A1 (pt) |
AT (1) | ATE208390T1 (pt) |
AU (1) | AU6739796A (pt) |
BG (1) | BG63780B1 (pt) |
BR (1) | BR9609951A (pt) |
CA (1) | CA2226934C (pt) |
CO (1) | CO4750836A1 (pt) |
CZ (1) | CZ291998B6 (pt) |
DE (2) | DE19528145A1 (pt) |
DK (1) | DK0843676T3 (pt) |
EE (1) | EE04614B1 (pt) |
ES (1) | ES2167592T3 (pt) |
HK (2) | HK1013597A1 (pt) |
HR (1) | HRP960365B1 (pt) |
HU (1) | HU228056B1 (pt) |
IL (1) | IL118986A (pt) |
MX (1) | MX9800864A (pt) |
MY (1) | MY115201A (pt) |
NO (1) | NO317561B1 (pt) |
NZ (1) | NZ315645A (pt) |
PL (1) | PL183789B1 (pt) |
PT (1) | PT843676E (pt) |
RO (1) | RO120260B1 (pt) |
RU (1) | RU2171258C2 (pt) |
SI (1) | SI0843676T1 (pt) |
SK (1) | SK283260B6 (pt) |
TR (1) | TR199800121T1 (pt) |
TW (1) | TW449597B (pt) |
UA (1) | UA55391C2 (pt) |
WO (1) | WO1997005136A1 (pt) |
YU (1) | YU49479B (pt) |
ZA (1) | ZA966494B (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
US20100197719A1 (en) * | 1999-05-12 | 2010-08-05 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
US20100310477A1 (en) * | 2000-11-28 | 2010-12-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg. | Pharmaceutical compositions based on anticholingerics and additional active ingredients |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US6455028B1 (en) * | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
AU2002303425A1 (en) * | 2001-04-24 | 2002-11-05 | Epigenesis Pharmaceuticals, Inc. | Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent |
US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20050043343A1 (en) * | 2003-07-28 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor |
US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20090317476A1 (en) * | 2003-07-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050038004A1 (en) * | 2003-07-31 | 2005-02-17 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050101545A1 (en) * | 2003-07-31 | 2005-05-12 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
PE20060826A1 (es) * | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
US20060239935A1 (en) * | 2005-04-23 | 2006-10-26 | Boehringer Ingelheim International Gmbh | Compositions for inhalation |
EP1879571A1 (de) * | 2005-04-23 | 2008-01-23 | Boehringer Ingelheim International GmbH | Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
TW201311649A (zh) * | 2011-09-05 | 2013-03-16 | Everlight Chem Ind Corp | 用於太陽能電池電解液之化合物及其製法、含有該化合物之電解液及太陽能電池 |
CN111751454B (zh) * | 2019-03-29 | 2023-12-08 | 天津药业研究院股份有限公司 | 一种异丙托溴铵中间体i的含量和有关物质的检测方法 |
CN110361494B (zh) * | 2019-06-26 | 2023-08-15 | 四川普锐特药业有限公司 | 异丙托溴铵气雾剂中杂质g的检测方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505337A (en) * | 1967-12-22 | 1970-04-07 | Boehringer Sohn Ingelheim | N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof |
DE2903957A1 (de) * | 1979-02-02 | 1980-08-07 | Boehringer Sohn Ingelheim | Mittel zur behandlung der nasalen hypersekretion |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
DE4140861C2 (de) * | 1991-12-11 | 2003-12-11 | Boehringer Ingelheim Kg | Verfahren zur Gewinnung von quartären Tropasäurealkaloiden |
RU2126248C1 (ru) * | 1992-12-09 | 1999-02-20 | Берингер Ингельхейм Фармасьютикалз, Инк. | Жидкая фармацевтическая композиция в форме аэрозоля |
-
1995
- 1995-08-01 DE DE19528145A patent/DE19528145A1/de not_active Withdrawn
-
1996
- 1996-07-10 TW TW085108367A patent/TW449597B/zh not_active IP Right Cessation
- 1996-07-29 YU YU44596A patent/YU49479B/sh unknown
- 1996-07-30 CZ CZ19962253A patent/CZ291998B6/cs not_active IP Right Cessation
- 1996-07-31 IL IL11898696A patent/IL118986A/en not_active IP Right Cessation
- 1996-07-31 CO CO96040544A patent/CO4750836A1/es unknown
- 1996-07-31 NZ NZ315645A patent/NZ315645A/xx not_active IP Right Cessation
- 1996-07-31 KR KR10-1998-0700661A patent/KR100445016B1/ko not_active IP Right Cessation
- 1996-07-31 CA CA002226934A patent/CA2226934C/en not_active Expired - Lifetime
- 1996-07-31 RU RU98103895/04A patent/RU2171258C2/ru active
- 1996-07-31 AU AU67397/96A patent/AU6739796A/en not_active Abandoned
- 1996-07-31 AT AT96927638T patent/ATE208390T1/de active
- 1996-07-31 EE EE9800028A patent/EE04614B1/xx unknown
- 1996-07-31 UA UA98021045A patent/UA55391C2/uk unknown
- 1996-07-31 ZA ZA966494A patent/ZA966494B/xx unknown
- 1996-07-31 PT PT96927638T patent/PT843676E/pt unknown
- 1996-07-31 HU HU9602104A patent/HU228056B1/hu unknown
- 1996-07-31 WO PCT/EP1996/003364 patent/WO1997005136A1/de active IP Right Grant
- 1996-07-31 TR TR1998/00121T patent/TR199800121T1/xx unknown
- 1996-07-31 DE DE59608156T patent/DE59608156D1/de not_active Expired - Lifetime
- 1996-07-31 RO RO98-00142A patent/RO120260B1/ro unknown
- 1996-07-31 HR HR960365A patent/HRP960365B1/xx not_active IP Right Cessation
- 1996-07-31 BR BR9609951A patent/BR9609951A/pt not_active IP Right Cessation
- 1996-07-31 MX MX9800864A patent/MX9800864A/es unknown
- 1996-07-31 CN CN96195701A patent/CN1120841C/zh not_active Expired - Lifetime
- 1996-07-31 JP JP9507251A patent/JPH11510150A/ja active Pending
- 1996-07-31 DK DK96927638T patent/DK0843676T3/da active
- 1996-07-31 EP EP96927638A patent/EP0843676B1/de not_active Expired - Lifetime
- 1996-07-31 SK SK112-98A patent/SK283260B6/sk not_active IP Right Cessation
- 1996-07-31 MY MYPI96003140A patent/MY115201A/en unknown
- 1996-07-31 ES ES96927638T patent/ES2167592T3/es not_active Expired - Lifetime
- 1996-07-31 SI SI9630405T patent/SI0843676T1/xx unknown
- 1996-07-31 PL PL96324804A patent/PL183789B1/pl unknown
- 1996-07-31 AR ARP960103824A patent/AR004179A1/es unknown
-
1998
- 1998-01-20 BG BG102202A patent/BG63780B1/bg unknown
- 1998-01-30 NO NO19980424A patent/NO317561B1/no not_active IP Right Cessation
- 1998-10-21 HK HK98111418A patent/HK1013597A1/xx not_active IP Right Cessation
- 1998-11-20 HK HK98112141A patent/HK1010879A1/xx unknown
-
1999
- 1999-08-06 US US09/369,711 patent/US6299861B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT843676E (pt) | Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada | |
DK0850059T3 (da) | Farmaceutiske formuleringer indeholdende darifenacin | |
DE19681287T1 (de) | Orale Formulierung von 2-Methylthienobenzodiazepin | |
DE69625368D1 (de) | Schweisshemmende deodorierende präparaten | |
ATE304351T1 (de) | Arzneizubereitungen enthaltend kannabinoide | |
DE69613647D1 (de) | Wasser-in-Öl-Emulsion enthaltendes kosmetisches Präparat | |
DE69624227D1 (de) | Substanzabgabevorrichtung | |
BR9611130A (pt) | Derivados de 3-aril-5-halógeno-pirona | |
NO981008D0 (no) | Farmasöytisk formulering | |
BR9610983A (pt) | Formas estáveis de administração farmacêuticas contendo paratormônio | |
KR970000228A (ko) | S-에토돌락의 경구용 제제 | |
BR9606674A (pt) | Novo derivado de composto de antraciclina e preparação farmacéutica contendo o mesmo | |
DE69526376D1 (de) | Film mit abgewinkelten kapillaren | |
FI965204A0 (fi) | Bromelaiinin lääkekäyttö | |
FI973229A0 (fi) | Uusi farmaseuttinen koostumus | |
BR9609081A (pt) | Combinações de substáncias ativas | |
FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
BR9607046A (pt) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas | |
DE59610423D1 (de) | Partikulare arzneiform | |
BR9606066A (pt) | Composto e formulação farmacêutica | |
NO964685L (no) | Isomering av equilin | |
DE69627417D1 (de) | Fluoreszierende-Weissmacher-enthaltende Zubereitungen | |
KR970015417U (ko) | 카운터가 착설된 아프리케이터 | |
KR960026743U (ko) | 주사기 | |
KR960036267U (ko) | 세척기 |